My Alcon | Language
This page is available in English....
Systane | Singapore
Systane Global Sites
Americas
Europe / Middle East / Africa
België - Nederlands / Français
Asia Pacific
COMING SOON
Americas
Mexico
Colombia
Chile
Argentina
Ecuador
Peru
Uruguay
Europe / Middle East / Africa
France
Asia Pacific
South Korea
China
My Dry Eyes don’t hold me back. Do Yours?
Are you putting up with irritated, sore and watery eyes? You may be suffering from dry eyes.
SYSTANE®’s range of products are designed to moisture and relieve the symptoms of dry eyes.
Find relief that’s right for you
Whether you need an everyday solution for fast, long-lasting dry eye relief1,2, preservative free for sensitive eyes3,5, or replenishing dry eye relief, SYSTANE® has got you covered.
Why Systane®?
Systane® is the
No. 1 Selling Eye Care Brand6
The Systane® family of eye drops contains a unique, patented ingredient, HP-Guar4, which helps deliver the Dry Eye relief you need so you can be unstoppable.
References:
1. Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353.
2. Christensen MT, Martin AE, Bloomenstein M. A comparison of efficacy between Systane Ultra and Optive lubricant eye drops when tested with dry eye patients. Optometry. 2009;80(6):315.
3. Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effects of a hyaluronic acid/hydroxypropyl guar artificial tear solution on protection, recovery, and lubricity in models of corneal epithelium. J Ocul Pharmacol Ther. 2015;31(8):491-497.
4. Rolando M, Autori S, Badino F, Barabino S. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J Ocul Pharmacol Ther. 2009;25(3):271-278.
5. Silverstein S, Yeu E, Tauber J, et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:3167-3177.
6. Nicholas Hall’s global OTC database, DB6 announced on 15 May 2019. Source: Internal calculations by ALcon based on IQVIA™Consumer Health Insights/MIDAS Audit, Dollars, MAT 06/2021.
Consult your healthcare or eye care professional for use, precautions, warnings and contraindications.